Three convergent routes to thiophenes are described, hinging on the radical addition of alpha-xanthyl ketones to ethyl vinyl sulfide or to vinyl pivalate. The latter route ultimately proved to be the most versatile and efficient (61-94%).
USEFUL THIOPHENE DERIVATIVES IN THE TREATMENT OF DIABETES
申请人:METABRAIN RESEARCH
公开号:US20150197530A1
公开(公告)日:2015-07-16
The present invention relates to a thiophene derivative of the following general formula I
or an enantiomer, diastereoisomer, hydrate, solvate, tautomer, racemic mixture or pharmaceutically acceptable salt thereof or to its use as a drug in particular intended for treating and/or preventing diabetes, its complications and/or associated pathologies, advantageously diabetes of type II and hyperglycemia.
Pyrazole-4-Carboxamide Derivatives as Microbiocides
申请人:Lamberth Clemens
公开号:US20080188442A1
公开(公告)日:2008-08-07
Compounds of the formula I in which the substituents are as defined in claim
1
are suitable for use as microbiocides.
式I中的化合物,其中取代基如权利要求1所定义的那样,适用于用作微生物杀菌剂。
N-AROYL CYCLIC AMINES
申请人:BRANCH Clive Leslie
公开号:US20090029986A1
公开(公告)日:2009-01-29
Disclosed are N-aroyl cyclic amine derivatives having the formula:
wherein the substituent variables are as defined herein, and their use as pharmaceuticals.
揭示了具有以下公式的N-芳酰基环状胺衍生物:
其中取代基变量如此定义,并且它们作为药物的用途。
TRANS-3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
申请人:Aissaoui Hamed
公开号:US20100204285A1
公开(公告)日:2010-08-12
The invention relates to novel trans-3-aza-bicyclo[3.1.0]hexane derivatives of formula (I), wherein A, B, n and R
1
are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.
1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity
申请人:SMITHKLINE BEECHAM PLC
公开号:EP1956020A2
公开(公告)日:2008-08-13
This invention relates to N-aroyl cyclic amine derivatives and their use as pharmaceuticals.